Ranbaxy Can't Dodge Lupin's Suit Over Generic Antara

Law360, New York (April 21, 2011, 7:52 PM EDT) -- A Pennsylvania federal judge on Thursday rejected Ranbaxy Laboratories Ltd.'s bid to nix a Lupin Ltd. unit's lawsuit seeking to block Ranbaxy from launching a generic version of the cholesterol drug Antara.

Judge Gene E. K. Pratter of the Eastern District of Pennsylvania denied Ranbaxy's motion to dismiss one of three lawsuits Lupin Atlantis Holdings SA has lodged accusing the generic-drug maker of infringing the patent that covers Antara with its proposed generic drug.

Ranbaxy's motion asked the court to dismiss the lawsuit because it is...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.